These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 25717387)

  • 1. A phase 2, single-arm study of an autologous dendritic cell treatment against mucin 1 in patients with advanced epithelial ovarian cancer.
    Mitchell PL; Quinn MA; Grant PT; Allen DG; Jobling TW; White SC; Zhao A; Karanikas V; Vaughan H; Pietersz G; McKenzie IF; Gargosky SE; Loveland BE
    J Immunother Cancer; 2014; 2():16. PubMed ID: 24995129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer?
    Fanale D; Corsini LR; Brando C; Cutaia S; Di Donna MC; Filorizzo C; Lisanti MC; Randazzo U; Magrin L; Romano R; Bazan Russo TD; Olive D; Vieni S; Pantuso G; Chiantera V; Russo A; Bazan V; Iovanna JL
    Front Oncol; 2022; 12():946319. PubMed ID: 36212445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Value of Elevated Pre-treatment Serum CA-125 in Epithelial Ovarian Cancer: A Meta-Analysis.
    Wang Q; Feng X; Liu X; Zhu S
    Front Oncol; 2022; 12():868061. PubMed ID: 35463345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between
    Xu MY; Cao B; Chen Y; Musial N; Wang S; Yin J; Liu L; Lu QB
    BMJ Open; 2018 Aug; 8(8):e022374. PubMed ID: 30139906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated growth differentiation factor 15 expression predicts poor prognosis in epithelial ovarian cancer patients.
    Zhang Y; Hua W; Niu LC; Li SM; Wang YM; Shang L; Zhang C; Li WN; Wang R; Chen BL; Xin XY; Zhang YQ; Wang J
    Tumour Biol; 2016 Jul; 37(7):9423-31. PubMed ID: 26781874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring ovarian cancer patients during chemotherapy and follow-up with the serum tumor marker CA125.
    Abu Hassaan SO
    Dan Med J; 2018 Apr; 65(4):. PubMed ID: 29619933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CA125 and Ovarian Cancer: A Comprehensive Review.
    Charkhchi P; Cybulski C; Gronwald J; Wong FO; Narod SA; Akbari MR
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33322519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Significance of Normal Pretreatment Levels of CA125 (<35 U/mL) in Epithelial Ovarian Carcinoma.
    Menczer J; Ben-Shem E; Golan A; Levy T
    Rambam Maimonides Med J; 2015 Jan; 6(1):e0005. PubMed ID: 25717387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined score of pretreatment platelet count and CA125 level (PLT-CA125) stratified prognosis in patients with FIGO stage IV epithelial ovarian cancer.
    Chen JP; Huang QD; Wan T; Tu H; Gu HF; Cao JY; Liu JH
    J Ovarian Res; 2019 Jul; 12(1):72. PubMed ID: 31362750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma.
    Morales-Vásquez F; Pedernera E; Reynaga-Obregón J; López-Basave HN; Gómora MJ; Carlón E; Cárdenas S; Silva-Ayala R; Almaraz M; Méndez C
    J Ovarian Res; 2016 Jul; 9(1):41. PubMed ID: 27388275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic relevance of high pretreatment CA125 levels in primary serous ovarian cancer.
    Bachmann R; Brucker S; Stäbler A; Krämer B; Ladurner R; Königsrainer A; Wallwiener D; Bachmann C
    Mol Clin Oncol; 2021 Jan; 14(1):8. PubMed ID: 33262888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative changes in serum CA125 levels: a prognostic factor for disease-specific survival in patients with ovarian cancer.
    Zwakman N; van de Laar R; Van Gorp T; Zusterzeel PL; Snijders MP; Ferreira I; Massuger LF; Kruitwagen RF
    J Gynecol Oncol; 2017 Jan; 28(1):e7. PubMed ID: 27670261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum CA125 levels predict outcome of interval debulking surgery after neoadjuvant chemotherapy in patients with advanced ovarian cancer.
    Zhang D; Jiang YX; Luo SJ; Zhou R; Jiang QX; Linghu H
    Clin Chim Acta; 2018 Sep; 484():32-35. PubMed ID: 29702068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of elevated preoperative serum CA125 in ovarian tumors of low malignant potential: a multinational collaborative study (ANZGOG0801).
    Tang A; Kondalsamy-Chennakesavan S; Ngan H; Zusterzeel P; Quinn M; Carter J; Leung Y; Obermair A
    Gynecol Oncol; 2012 Jul; 126(1):36-40. PubMed ID: 22370601
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.